Weekly Insights & Analysis
Healthcare Private Placement and M&A Transactions Review Week Ending September 1, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Navigator Medicines: The company raised $100 million of Series A venture funding in a deal led by RA Capital Management and Forbion on August 27, 2024, putting the company's pre-money...
Technology Private Placement and M&A Transactions Review Week Ending August 25, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Submittable: The company raised $91.4 million of venture funding from undisclosed investors on August 21, 2024. The company is a developer of a cloud-based web submission management platform....
Consumer Private Placement and M&A Transactions Review Week Ending August 25, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Papa's Pilar: The company received $15 million of development capital from undisclosed investors on August 19, 2024. The company is a manufacturer of multi-sourced rums and alcoholic...
Healthcare Private Placement and M&A Transactions Review Week Ending August 25, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Borealis Biosciences: The company raised $150 million of Series A venture funding from Novartis and Versant Ventures on August 22, 2024. The company is an operator of a discovery-stage...
Technology Private Placement and M&A Transactions Review Week Ending August 18, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions EliseAI: The company raised $75 million through a combination of debt and Series D venture funding in a deal led by Sapphire Ventures on August 14, 2024, putting the company's pre-money...
A weekly digest of strategy and finance perspectives in charts, together with a review of M&A and private placement transactions by industry sector.